Keefe, Bruyette & Woods dropped its price objective while Raymond James Financial set a new objective, with MarketBeat reporting consensus ratings.

The entities involved

• Keefe, Bruyette & Woods →

  investment bank

  • Keefe, Bruyette & Woods raised its shares rating for Skandinaviska Banken.Tue 11:46
  • Keefe, Bruyette & Woods increased its target price for WaFd Bank on June 19, 2026.Tue 09:45
• Raymond James Financial →

  American Investment Bank and Financial Services Firm

  • Raymond James Financial assumed coverage on Odyssey Therapeutics, and Manufacturers Life Insurance Company purchased a new position in its shares.09:16
  • Raymond James Financial upgraded HLS Therapeutics stock rating to strong-buy on August 14, 2026.04:27
• MarketBeat →

  American personal finance blog

  • MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.08:34
  • MarketBeat provided average rating data for HeartSciences on September 14, 2026.08:20

Related events

• Keefe, Bruyette & Woods reduced its price objective for Simmons Bank on October 21, 2026.Oct 22
• Keefe, Bruyette & Woods boosted its price objective on Assurant while Morgan Stanley reduced its price target on the shares.Wed 16:57
• Keefe, Bruyette & Woods decreased its target price for CoStar Group, with MarketBeat providing consensus rating data.Jul 2
• Keefe, Bruyette & Woods lifted its price objective for TMP, with MarketBeat providing consensus rating data.Oct 22
• Keefe, Bruyette & Woods and Raymond James Financial issued rating upgrades and target price increases for FirstSun Capital Bancorp.Oct 31